US Hearing Screening Diagnostic Devices Market

ID: MRFR/MED/18115-HCR
100 Pages
Nidhi Mandole
Last Updated: April 06, 2026
US Hearing Screening Diagnostic Devices Market Research Report By Product (OAE/ABR Testing Devices, Audiometers, Immittance Screeners), By Age (Newborn Hearing Screening, Others), By Indication (Conductive Hearing Loss, Sensorineural Hearing Loss, Combination Hearing Loss), By Test (Pure-tone Test, Bone Conduction Test) and By End User (Hospital & Clinics, Diagnostic Centers) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Hearing Screening Diagnostic Devices Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)6.72%
2024 Market Size$ 1.33 Billion
2025 Market Size$ 1.43 Billion
2035 Market Size$ 2.72 Billion

Key Players

Oticon
Cochlear
GN Hearing
Demant
Amplifon
Sonova
Trends
  • Technological Advancements in Screening Devices
  • Increased Focus on Preventive Healthcare
  • Regulatory Support and Standards
Opportunities
  • Regulatory Support and Standards
  • Integration of Telehealth Services
  • Rising Incidence of Hearing Disorders
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Application (USD Billion)
      1. 4.1.1 Screening
      2. 4.1.2 Diagnosis
      3. 4.1.3 Monitoring
      4. 4.1.4 Research
    2. 4.2 Healthcare, BY End Use (USD Billion)
      1. 4.2.1 Hospitals
      2. 4.2.2 Clinics
      3. 4.2.3 Home Care
      4. 4.2.4 Diagnostic Laboratories
    3. 4.3 Healthcare, BY Device Type (USD Billion)
      1. 4.3.1 Audiometers
      2. 4.3.2 Otoacoustic Emissions Devices
      3. 4.3.3 Tympanometers
      4. 4.3.4 Hearing Screening Software
    4. 4.4 Healthcare, BY Technology (USD Billion)
      1. 4.4.1 Pure Tone Audiometry
      2. 4.4.2 Automated Auditory Brainstem Response
      3. 4.4.3 Otoacoustic Emissions Testing
      4. 4.4.4 Impedance Audiometry
    5. 4.5 Healthcare, BY Patient Demographics (USD Billion)
      1. 4.5.1 Pediatric
      2. 4.5.2 Adult
      3. 4.5.3 Geriatric
      4. 4.5.4 Special Needs
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Oticon (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Cochlear (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 GN Hearing (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Demant (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Amplifon (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Sonova (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Starkey Hearing Technologies (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Eargo (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 WS Audiology (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY APPLICATION
    3. 6.3 US MARKET ANALYSIS BY END USE
    4. 6.4 US MARKET ANALYSIS BY DEVICE TYPE
    5. 6.5 US MARKET ANALYSIS BY TECHNOLOGY
    6. 6.6 US MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF HEALTHCARE
    10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
    13. 6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    14. 6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    15. 6.15 HEALTHCARE, BY END USE, 2024 (% SHARE)
    16. 6.16 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
    17. 6.17 HEALTHCARE, BY DEVICE TYPE, 2024 (% SHARE)
    18. 6.18 HEALTHCARE, BY DEVICE TYPE, 2024 TO 2035 (USD Billion)
    19. 6.19 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
    20. 6.20 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
    21. 6.21 HEALTHCARE, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE)
    22. 6.22 HEALTHCARE, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Billion)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
      2. 7.2.2 BY END USE, 2026-2035 (USD Billion)
      3. 7.2.3 BY DEVICE TYPE, 2026-2035 (USD Billion)
      4. 7.2.4 BY TECHNOLOGY, 2026-2035 (USD Billion)
      5. 7.2.5 BY PATIENT DEMOGRAPHICS, 2026-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Hearing Screening Diagnostic Devices Market Segmentation

US Hearing Screening Diagnostic Devices Market By Application (USD Billion, 2026-2035)

  • Screening
  • Diagnosis
  • Monitoring
  • Research

US Hearing Screening Diagnostic Devices Market By End Use (USD Billion, 2026-2035)

  • Hospitals
  • Clinics
  • Home Care
  • Diagnostic Laboratories

US Hearing Screening Diagnostic Devices Market By Device Type (USD Billion, 2026-2035)

  • Audiometers
  • Otoacoustic Emissions Devices
  • Tympanometers
  • Hearing Screening Software

US Hearing Screening Diagnostic Devices Market By Technology (USD Billion, 2026-2035)

  • Pure Tone Audiometry
  • Automated Auditory Brainstem Response
  • Otoacoustic Emissions Testing
  • Impedance Audiometry

US Hearing Screening Diagnostic Devices Market By Patient Demographics (USD Billion, 2026-2035)

  • Pediatric
  • Adult
  • Geriatric
  • Special Needs

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035